Tag: NASDAQ:ALDX

Science

Aldeyra Therapeutics Inc (NASDAQ: ALDX) Stock: Does It Mean Opportunity?

In today’s recent session, 1.37 million shares of the Aldeyra Therapeutics Inc (NASDAQ:ALDX) have been traded, and its beta is 1.35. Most recently the company’s

Business

Analysts Say Aldeyra Therapeutics Inc (NASDAQ:ALDX) Can Really Get To 12 In 12 Months

In last trading session, Aldeyra Therapeutics Inc (NASDAQ:ALDX) saw 0.34 million shares changing hands with its beta currently measuring 1.37. Company’s recent per share price

Technologies

The $5.37 Is The Price At Which Aldeyra Therapeutics Inc (NASDAQ: ALDX) Deserves Consideration

During the last session, Aldeyra Therapeutics Inc (NASDAQ:ALDX)’s traded shares were 0.42 million, with the beta value of the company hitting 1.43. At the end

Technologies

Should You Expect A Quick Recovery From Aldeyra Therapeutics Inc (NASDAQ: ALDX) After -22.66% Decline From High?

Aldeyra Therapeutics Inc (NASDAQ:ALDX)’s traded shares stood at 0.36 million during the last session, with the company’s beta value hitting 1.43. At the close of

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: NASDAQ:ALDX

Aldeyra Therapeutics Inc (NASDAQ: ALDX) Stock: Does It Mean Opportunity?

Analysts Say Aldeyra Therapeutics Inc (NASDAQ:ALDX) Can Really Get To 12 In 12 Months

The $5.37 Is The Price At Which Aldeyra Therapeutics Inc (NASDAQ: ALDX) Deserves Consideration

Should You Expect A Quick Recovery From Aldeyra Therapeutics Inc (NASDAQ: ALDX) After -22.66% Decline From High?

Quick Links

Categories